3860 — EPS Creative Health Technology Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro CapNeutral

Annual income statement for EPS Creative Health Technology, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	405	520	453	645	545
Cost of Revenue
Gross Profit	54	76.8	67.8	99.3	94.6
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	398	538	495	662	503
Operating Profit	7.27	-18.1	-42.4	-17	41.7
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	7.14	-22.7	-48.2	-24.1	33.4
Provision for Income Taxes
Net Income After Taxes	6.5	-26.3	-50.3	-26.5	30.4
Minority Interest
Net Income Before Extraordinary Items
Net Income	6.5	-22.6	-45.7	-22.1	38.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	6.5	-22.6	-45.7	-22.1	38.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.013	-0.045	-0.093	-0.044	0.03
Dividends per Share